https://www.selleckchem.com/pr....oducts/2-aminoethyl-
ample and validation of the software are needed to confirm if this can be used to guide surveillance schedules for dissolution therapy. The mounting incidence of multidrug-resistant bacterial strains and the dearth of novel antibiotics demand alternate therapies to manage the infections caused by resistant superbugs. Bacteriophages and phage=derived proteins are considered as potential alternates to treat such infections, and have several applications in health care systems. The aim of this review is to explore the